Ketorolac inhibits choroidal neovascularization by suppression of retinal VEGF

Experimental Eye Research

Volumn 91, Issue 4, 2010, Pages 537-543

  Kim, Stephen J ^a   Toma, Hassanain S ^a   Barnett, Joshua M ^b   Penn, John S ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age related macular degeneration; AMD; Choroidal neovascularization; CNV; COX 2; Cyclooxygenase; Ketorolac; Laser induced CNV; Nonsteroidal anti inflammatory drugs; NSAIDs

Indexed keywords

ARTIFICIAL TEAR; KETOROLAC TROMETAMOL; OPTIVE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG; VASCULOTROPIN; KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOROID; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FLUORESCENCE ANGIOGRAPHY; LASER COAGULATION; MALE; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RAT; SCLERA; SUBRETINAL NEOVASCULARIZATION; TREATMENT RESPONSE; VITREOUS BODY; ANIMAL; ANTAGONISTS AND INHIBITORS; BROWN NORWAY RAT; CHOROIDAL NEOVASCULARIZATION; DISEASE MODEL; DRUG EFFECTS; METABOLISM; RETINA; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHOROIDAL NEOVASCULARIZATION; DINOPROSTONE; DISEASE MODELS, ANIMAL; FLUORESCEIN ANGIOGRAPHY; KETOROLAC; MALE; RATS; RATS, INBRED BN; RETINA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 79955954484     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2010.07.011     Document Type: Article

References (30)

1. Amrite A.C., Ayalasomayajula S.P., Cheruvu N.P., Kompella U.B. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage. Invest. Ophthalmol. Vis. Sci. 2006, 47:1149-1160.
2. Bora P.S., Sohn J.H., Cruz J.M., Jha P., Nishihori H., Wang Y., Kaliappan S., Kaplan H.J., Bora N.S. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J. Immunol. 2005, 174:491-497.
3. Cheng T., Cao W., Wen R., Stenberg R.H., LaVail M.M. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat muller cells. Invest. Ophthalmol. Vis. Sci. 1998, 39:581-591.
4. Chin M.S., Nagineni C.N., Hooper L.C., Detrick B., Hooks J.J. Cyclooxygenase-2 gene expression and regulation in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 2001, 42:2338-2346.
5. Cohen S.Y., Laroche A., Leguen Y., Soubrane G., Coscas G.J. Etiology of choroidal neovascularization in young patients. Ophthalmology 1996, 103:1241-1244.
6. Edelman J.L., Castro M.R. Quantitative image analysis of laser-induced choroidal neovascularization in rat. Exp. Eye Res. 2000, 71:523-533.
7. Grossniklaus H.E., Ling J.X., Wallace T.M., Dithmar S., Lawson D.H., Cohen C., Elner V.M., Elner S.G., Sternberg P. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol. Vis. 2002, 8:119-126.
8. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421.
9. Hatazawa R., Tanigami M., Izumi N., Kamei K., Tanaka A., Takeuchi K. Prostaglandin E2 stimulates VEGF expression in primary rat gastric fibroblasts through EP4 receptors. Inflammopharmacology 2007, 15:214-217.
10. Hu W., Criswell M.H., Ottlecz A., Cornell T.L., Danis R.P., Lambrou G.N., Ciulla T.A. Oral administration of lumiracoxib reduces choroidal neovascular membrane development in the rat laser-trauma model. Retina 2005, 25:1054-1064.
11. Kedhar S.R., Thorne J.E., Wittenberg S., Dunn J.P., Jabs D.A. Multifocal choroiditis with panuveitis and punctate inner choroidopathy: comparison of clinical characteristics at presentation. Retina 2007, 27:1174-1179.
12. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
13. Kim S.J., Flach A.J., Jampol L.M. Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv. Ophthalmol. 2010, 55:108-133.
14. Kim S.J., Toma H.S. Inhibition of choroidal neovascularization by intravitreal ketorolac. Arch. Ophthalmol 2010, 128:596-600.
15. Lee S.H., Kim M.H., Han H.J. Arachidonic acid potentiates hypoxia-induced VEGF expression in mouse embryonic stem cells: involvement of Notch, Wnt, and HIF-1alpha. Am. J. Physiol. Cell Physiol. 2009, 297:C207-C216.
16. Lopez P.F., Grossniklaus H.E., Lambert H.M., Aaberg T.N., Capone A., Sternberg P., L'Hernault N. Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration. Am. J. Ophthalmol. 1991, 112:647-656.
17. Maloney S.C., Fernandes B.F., Castiglione E., Antecka E., Martins C., Marshall J.C., Di Cesare S., Logan P., Burnier M.N. Expression of cyclooxygenase-2 in choroidal neovascular membranes from age-related macular degeneration patients. Retina 2009, 29:176-180.
18. Miller H., Miller B., Ishibashi T., Ryan S.J. Pathogenesis of laser-induced choroidal subretinal neovascularization. Invest. Ophthalmol. Vis. Sci. 1990, 31:899-908.
19. Nozaki M., Raisler B.J., Sakurai E., Sarma J.V., Barnum S.R., Lambris J.D., Chen Y., Zhang K., Ambati B.K., Baffi J.Z., Ambati J. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2328-2333.
20. Olsen J.L., Courtney R.J., Mandava N. Intravitreal infliximab and choroidal neovascularization in an animal model. Arch. Ophthalmol. 2007, 125:1221-1224.
21. Olson J.L., Courtney R.J., Rouhani B., Mandava N., Dinarello C.A. Intravitreal anakinra inhibits choroidal neovascular membrane growth in a rat model. Ocul. Immunol. Inflamm. 2009, 17:195-200.
22. Patel M., Chan C.C. Immunopathological aspects of age-related macular degeneration. Semin. Immunopathol. 2008, 20:97-110.
23. Rodrigues E.B. Inflammation in dry age-related macular degeneration. Ophthalmologica 2007, 2007(221):143-152.
24. Sakamoto T., Soriana D., Nassaralla J., Murphy T.L., Oganesian A., Spee C., Hinton D.R., Ryan S.J. Effect of intravitreal administration of indomethacin on experimental subretinal neovascularization in the subhuman primate. Arch. Ophthalmol. 1995, 113:222-226.
25. Soubrane G. Choroidal neovascularization in pathologic myopia: recent developments in diagnosis and treatment. Surv. Ophthalmol. 2008, 53:121-138.
26. Takahashi K., Saishin Y., Saishin Y., Mori K., Ando A., Yamamoto S., Oshima Y., Nambu H., Melia M.B., Bingaman D.P., Campochiaro P.A. Topical nepafenac inhibits ocular neovascularization. Invest. Ophthalmol. Vis. Sci. 2003, 44:409-415.
27. Takahashi H., Yanagi Y., Tamaki Y., Uchida S., Muranaka K. COX-2-selective inhibitor, etodolac, suppresses choroidal neovascularization in a mice model. Biochem. Biophys. Res. Commun. 2004, 325:461-466.
28. Wilson H.L., Schwartz D.M., Bhatt H.R., McCulloch C.E., Duncan J.L. Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration. Am. J. Ophthalmol. 2004, 137:615-624.
29. Yanni S.E., Barnett J.M., Clark M.L., Penn J.S. The role of PGE2 receptor EP4 in pathologic ocular angiogenesis. Invest. Ophthalmol. Vis. Sci. 2009, 50:5479-5486.
30. Yu H.G., Liu X., Kiss S., Connolly E., Gragoudas E.S., Michaud N.A., Bulgakov O.V., Adamian M., DeAngelis M.M., Miller J.W., Li T., Kim I.K. Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1. Invest. Ophthalmol. Vis. Sci. 2008, 49:2599-2605.